Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells

[1]  H. Yang,et al.  A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[3]  M. Kaplan,et al.  Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice , 1996, Nature.

[4]  P. Doherty,et al.  Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells , 1996, Nature.

[5]  D. Carvajal,et al.  IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses , 1996 .

[6]  W. Paul,et al.  Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene , 1996, Nature.

[7]  S. Akira,et al.  Essential role of Stat6 in IL-4 signalling , 1996, Nature.

[8]  U. Wahn,et al.  Effects of interferon‐α on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen‐specific T cells , 1996, European journal of immunology.

[9]  M. Kaplan,et al.  Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. , 1996, Immunity.

[10]  K. Murphy,et al.  Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. , 1996, Journal of immunology.

[11]  U. Gubler,et al.  Cloning and characterization of a mouse IL-12 receptor-beta component. , 1995, Journal of immunology.

[12]  E. Appella,et al.  The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  E. Petricoin,et al.  Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Szabo,et al.  Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. , 1995, Immunity.

[15]  S. Szabo,et al.  Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4 , 1995, The Journal of experimental medicine.

[16]  R. Rees,et al.  Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL- 12 , 1995, The Journal of experimental medicine.

[17]  R. Seder.  Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, The Journal of allergy and clinical immunology.

[18]  R. de Waal Malefyt,et al.  IL-12 transiently induces IFN-gamma transcription and protein synthesis in human CD4+ allergen-specific Th2 T cell clones. , 1994, International immunology.

[19]  M. Gately,et al.  Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. , 1994, Journal of immunology.

[20]  G. Trinchieri,et al.  Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones , 1994, The Journal of experimental medicine.

[21]  M. Piccinni,et al.  Interleukin 12 Induces Stable Priming for Interferon 3' (IFN-3") Production During Differentiation of Human T Helper (Th) Cells and Transient IFN-3' Production in Established Th2 Cell Clones By Roberto Manetti,* Franca Gerosa,~ Maria Grazia Giudizi,* , 1994 .

[22]  S. Romagnani.  Lymphokine production by human T cells in disease states. , 1994, Annual review of immunology.

[23]  W. Paul,et al.  Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, Annual review of immunology.

[24]  A. Sher,et al.  Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[26]  G. Trinchieri,et al.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.

[27]  Martin Bachmann,et al.  Disruption of the murine IL-4 gene blocks Th2 cytokine responses , 1993, Nature.

[28]  R. Coffman,et al.  Mechanism and regulation of immunoglobulin isotype switching. , 1993, Advances in immunology.

[29]  W. Paul,et al.  The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice , 1992, The Journal of experimental medicine.

[30]  C. Hsieh,et al.  Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  F. Podlaski,et al.  IL-12 receptor. I. Characterization of the receptor on phytohemagglutinin-activated human lymphoblasts. , 1992, Journal of immunology.

[32]  J. Guardiola,et al.  Identification of a CD4 binding site on the β2 domain of HLA-DR molecules , 1992, Nature.

[33]  K. Rajewsky,et al.  Generation and analysis of interleukin-4 deficient mice. , 1991, Science.

[34]  F. Sinigaglia,et al.  Selection of T cell epitopes and vaccine engineering. , 1991, Methods in enzymology.

[35]  E. Coligan.  Current protocols in immunology , 1991 .

[36]  J. Schmidt,et al.  A simple, rapid and large capacity ELISA for biologically active native and recombinant human IFN gamma. , 1987, Journal of biological regulators and homeostatic agents.

[37]  A. Lanzavecchia,et al.  The use of hybrid hybridomas to target human cytotoxic T lymphocytes , 1987, European journal of immunology.

[38]  A. Norton,et al.  Monoclonal antibody (UCHL1) that recognises normal and neoplastic T cells in routinely fixed tissues. , 1986, Journal of clinical pathology.

[39]  G A McPherson,et al.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. , 1985, Journal of pharmacological methods.

[40]  G. Trinchieri,et al.  Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. , 1983, Journal of immunology.